Redstone Research was formed by individual, independent consultants who recognized the need for their collective efforts on a clinical trial team. Our team consists of research professionals located throughout the United States with a proven history of successfully working together on previous projects. Collectively, our long-lasting working relationships with investigative sites are utilized for the success of an entire clinical trial. We are a Clinical Research Consulting and Functional Service Providor company with a large scope of services and trial management experience. Each member of our team enhances the services and efforts highlighted in our mission. Through years of experience and a valued interest in clinical trial research, the Redstone team proves to be a solid choice in conducting your trials.
Robert O. Kerr M.D.
Dr. Robert Kerr has been involved in laboratory and clinical research for more than twenty-five years and has been invited to present the results of his research in both the United States and Europe. He is the author of numerous publications and has served as president of the Texas Division of the American Cancer Society, president of the Texas Society of Medical Oncology, and chief of medical staff at two hospitals in Austin, TX. Additionally he has served as chairman and member of several state and national committees. Dr. Kerr is a regular presenter of Oncology CME. He is a member of the American Society of Clinical Oncology, the American Society of Hematology, and the European Society of Medical Oncology. He is board certified in Internal Medicine and Hematology. More recently, Dr. Kerr has served on the review board of 2 IRBs reviewing over 150 investigative plans. Prior to dedicating his time to support pharmaceutical IND applications, Dr. Kerr founded and practiced oncology at Southwest Regional Cancer Center now part of US Oncology.
Dr. Kerr is a Magna Cum Laude graduate of Elizabethtown College, and an AA graduate from University of Pittsburgh School of Medicine. After completing an internship and residency in Internal Medicine at the University of Pittsburgh Hospitals, he completed a fellowship at the University of Minnesota. Dr. Kerr has held faculty positions at the University of Minnesota and the University of Texas- San Antonio.
A. Lelo Diaz
Prior to clinical research Lelo Diaz conducted preclinical research through the Biomedical Research Training Program at the University of Texas at Austin. He has been working in clinical trials since 2001. As a medical student at The University of Texas in Galveston he was introduced to the clinical research industry. While on leave from school he worked as a Research Coordinator. This led to various roles in Clinical Operations within CROs and Sponsor companies. Mr. Diaz then opened Redstone Research to continue in the clinical development and marketing of novel therapeutics.
Although primarily focused on Medical Devices and Oncology, Mr. Diaz has successfully driven trials to completion in most therapeutic areas. Highlights include writing a research protocol and securing funding for a trial conducted in eight different countries. Additionally, he has attended FDA CDER workshops focused on the requirements and compliance of policies for marketing drug products.
Mr. Diaz has a bachelor of science in Biology from Southern Methodist University. He is a member of the Drug Information Association, the Association of Clinical Research Professionals, BioAustin, Associate Member of the American Society of Clinical Oncology, and a Board Member for the Environmental Healthcare Foundation.